Artificial intelligence use for precision medicine in inflammatory bowel disease: a systematic review.

Hugo Dugolin Ceccato¹, Thiago Antunes de Oliveira E Silva¹, Livia Moreira Genaro¹, Julian Furtado Silva¹, William Moraes de Souza¹, Priscilla de Sene Portel Oliveira¹, Anibal Tavares de Azevedo², Maria de Lourdes Setsuko Ayrizono¹, Raquel Franco Leal¹

¹Inflammatory Bowel Disease Research Laboratory, Gastrocenter, Colorectal Surgery Unit, School of Medical Sciences, University of Campinas (Unicamp) Campinas, São Paulo, Brazil.

²Simulation Laboratory (SimuLab), School of Applied Sciences, University of Campinas (Unicamp) Limeira, São Paulo, Brazil.

PubMed PMC DOI PDF

Abstract

INTRODUCTION: Inflammatory Bowel Disease (IBD), encompassing Crohn's disease and ulcerative colitis, presents significant clinical challenges due to its heterogeneous nature and complex etiology. Recent advancements in biomedical research have enhanced our understanding of IBD's genetic, microbial, and biochemical aspects. However, persistent issues in clinical management, including treatment non-…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.